Cargando…

A review of weight loss and sarcopenia in patients with head and neck cancer treated with chemoradiation

BACKGROUND: Concurrent chemotherapy and radiation (CTRT) improves disease-free survival in locally advanced head and neck cancer but is associated with numerous acute and chronic toxicities resulting in substantial alterations in body mass and composition. We aim to summarize the current evidence on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxi, Shrujal S., Schwitzer, Emily, Jones, Lee W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460633/ https://www.ncbi.nlm.nih.gov/pubmed/31093339 http://dx.doi.org/10.1186/s41199-016-0010-0

Ejemplares similares

Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation
por: Naumann, Patrick, et al.
Publicado: (2019)

Photobiomodulation During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence
por: Krc, Rebecca F., et al.
Publicado: (2023)

Sarcopenia and Treatment Toxicity in Older Adults Undergoing Chemoradiation for Head and Neck Cancer: Identifying Factors to Predict Frailty
por: Morse, Ryan T., et al.
Publicado: (2022)

Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancer
por: Baxi, Shrujal S., et al.
Publicado: (2016)

Sarcopenia in head and neck cancer: A scoping review
por: Jovanovic, Nedeljko, et al.
Publicado: (2022)

Narrative review of the management of oral mucositis during chemoradiation for head and neck cancer
por: Judge, Lauren F., et al.
Publicado: (2021)

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy
por: Thureau, Sébastien, et al.
Publicado: (2021)

Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation
por: Kaźmierska, Joanna, et al.
Publicado: (2023)

The Effect of Radiation and Chemoradiation Therapy on the Head and Neck Mucosal Microbiome: A Review
por: Zagury-Orly, Ivry, et al.
Publicado: (2021)

Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review
por: Jacobi, Irene, et al.
Publicado: (2010)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine
por: Pattanayak, Lucy, et al.
Publicado: (2016)

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
por: Vreugdenhil, M., et al.
Publicado: (2021)

A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study
por: Salz, Talya, et al.
Publicado: (2016)

Diffusion-weighted Magnetic Resonance Imaging for Predicting Response to Chemoradiation Therapy for Head and Neck Squamous Cell Carcinoma: A Systematic Review
por: Chung, Sae Rom, et al.
Publicado: (2019)

Moving survivorship care plans forward: focus on care coordination
por: Salz, Talya, et al.
Publicado: (2016)

Correlation of 3DCRT and Open Field Treatment Techniques in Advanced Head and Neck Cancer Patients Treated by Chemoradiation
por: Sachan, Anjali, et al.
Publicado: (2022)

Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation
por: Yu, Brian, et al.
Publicado: (2023)

The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy
por: Bentahila, Rita, et al.
Publicado: (2022)

When the Loss Costs Too Much: A Systematic Review and Meta-Analysis of Sarcopenia in Head and Neck Cancer
por: Hua, Xin, et al.
Publicado: (2020)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Intravenous fluids for pain management in head and neck cancer patients undergoing chemoradiation
por: Rivers, Charlotte I., et al.
Publicado: (2021)

Effect of vocal rehabilitation after chemoradiation for non-laryngeal head and neck cancers
por: Sreenivas, Athulya, et al.
Publicado: (2021)

Assessment of the Role of Gefitinib With Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
por: Prajapati, Raju, et al.
Publicado: (2022)

Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer
por: Ma, Sung Jun, et al.
Publicado: (2022)

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
por: van der Vorst, Maurice J. D. L., et al.
Publicado: (2019)

Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
por: Ghadjar, Pirus, et al.
Publicado: (2015)

Nutritional surveillance and weight loss in head and neck cancer patients
por: Ehrsson, Ylva Tiblom, et al.
Publicado: (2011)

Weight Loss in Post-Chemoradiotherapy Head and Neck Cancer Patients
por: Abu Zaid, Zalina, et al.
Publicado: (2022)

A Unique Complication Associated with Concurrent Chemoradiation for the Treatment of Locally Advanced Head and Neck Cancer
por: Cahlon, Oren, et al.
Publicado: (2008)

Sarcopenia is associated with blood transfusions in head and neck cancer free flap surgery
por: Jones, Alexander Joseph, et al.
Publicado: (2021)

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Analysis of pharyngeal edema post‐chemoradiation for head and neck cancer: Impact on swallow function
por: Turcotte, Maria C., et al.
Publicado: (2018)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

A Comparison of the Toxicities in Patients With Locally Advanced Head and Neck Cancers Treated With Concomitant Boost Radiotherapy Versus Conventional Chemoradiation
por: Sharma, Ritu, et al.
Publicado: (2023)

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
por: Jun, H J, et al.
Publicado: (2008)

Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis
por: Takenaka, Yukinori, et al.
Publicado: (2021)

Effects of Exercise Training during Concomitant Chemoradiation Therapy in Head-and-Neck Cancer Patients: A Systematic Review
por: D’souza, Macrina, et al.
Publicado: (2020)

Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
por: Melotek, James M., et al.
Publicado: (2016)

FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer
por: Ulrich, Ethan J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gmmbrgc6q74sahltq1d5on79ap